Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
STOCKHOLM, June 16, 2018 /PRNewswire/ -- Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Unfortunately, 40% of patients will relapse ...
Lees verderSTOCKHOLM, June 16, 2018 /PRNewswire/ -- B acute lymphoblastic leukemia (B-ALL) is a fatal blood cell tumor that is usually treated with chemotherapy or allogeneic ...
Lees verderSTOCKHOLM, June 16, 2018 /PRNewswire/ -- Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical ...
Lees verderSTOCKHOLM, June 15, 2018 /PRNewswire/ -- Iron is a vital element required for several biologic functions, first of all oxygen delivery to tissues, which occurs through the ...
Lees verderMADRID, June 24, 2017 /PRNewswire/ -- CTL019 consists of genetically engineered autologous T cells expressing a chimeric antigen receptor (CAR). Results from a prior ...
Lees verderMADRID, June 24, 2017 /PRNewswire/ -- Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with eight or six cycles of eBEACOPP is very ...
Lees verderMADRID, June 24, 2017 /PRNewswire/ -- Outcomes for patients with refractory, aggressive non-Hodgkin lymphoma (NHL) are poor with current therapies. Axicabtagene ciloleucel ...
Lees verderMADRID, June 24, 2017 /PRNewswire/ -- Ibrutinib: A promising new treatment for chronic graft versus host disease. Chronic graft versus host disease (cGVHD) is a serious and ...
Lees verderMADRID, June 24, 2017 /PRNewswire/ -- The risk of blood clots in the veins of the legs or the lungs, known as venous thrombosis (VTE) is higher in cancer patients, and so is ...
Lees verder